[Imatinib is a useful adjuvant drug even in PDGRFA/FIP1L1-negative HES.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE